Stocks and Investing
Stocks and Investing
Tue, January 5, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kevin DeGeeter Initiated (TSHA) at Buy on, Jan 5th, 2021
Kevin DeGeeter of Oppenheimer, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Buy on, Jan 5th, 2021.
Kevin has made no other calls on TSHA in the last 4 months.
There are 4 other peers that have a rating on TSHA. Out of the 4 peers that are also analyzing TSHA, 0 agree with Kevin's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Kevin
- Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $34 on, Monday, October 19th, 2020
- Gbola Amusa of "Chardan Capital" Initiated at Strong Buy and Held Target at $45 on, Monday, October 19th, 2020
- Matthew Harrison of "Morgan Stanley" Initiated at Buy on, Monday, October 19th, 2020
- Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $31 on, Monday, October 19th, 2020
Contributing Sources